Low-dose nivolumab induced durable complete response in relapsed primary central nervous system diffuse large B cell lymphoma

Ann Hematol. 2019 Sep;98(9):2227-2230. doi: 10.1007/s00277-019-03758-z. Epub 2019 Jul 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Magnetic Resonance Imaging
  • Male
  • Nivolumab / administration & dosage*

Substances

  • Nivolumab